Brainstorm Cell Therapeutics Inc Share Price OTC Bulletin Board
Equities
US10501E2019
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
17/04 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
17/04 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.53Cr 293.63Cr |
---|---|---|---|---|---|
Net income 2024 * | -2.1Cr -174.86Cr | Net income 2025 * | -2.7Cr -224.82Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.84
x | P/E ratio 2025 * |
-1.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.84% |
Latest transcript on Brainstorm Cell Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01/07/01 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23/12/23 |
Chief Tech/Sci/R&D Officer | - | 12/22/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22/00/22 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/14/06 |
Jacob Frenkel
CHM | Chairman | 81 | 30/20/30 |
1st Jan change | Capi. | |
---|---|---|
+32.30% | 5.08TCr | |
+1.08% | 4.28TCr | |
+49.28% | 4.2TCr | |
-4.22% | 2.95TCr | |
+10.78% | 2.61TCr | |
-21.61% | 1.91TCr | |
+9.01% | 1.31TCr | |
+27.37% | 1.22TCr | |
+23.54% | 1.21TCr |